Fennec Pharmaceuticals Inc.
FRX.TOTSXHealthcare● Active
$12.44
$-0.28(-2.20%)
Market Cap$355535511
P/E Ratio—
52W High$14.24
52W Low$7.59
Fennec Pharmaceuticals Inc. (FRX.TO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FRX.TO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $36.72M | $26.63M | $13.27M | $23.77M | $21.10M |
| Net Receivables | $23.18M | $12.88M | $8.81M | $1.54M | $0.00M |
| Inventory | $1.56M | $1.06M | $2.16M | $0.58M | $0.00M |
| Total Current Assets | $66.56M | $44.12M | $26.86M | $26.73M | $22.39M |
| PP&E Net | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $70.07M | $44.95M | $26.86M | $26.94M | $22.41M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $4.63M | $3.24M | $3.78M | $2.39M | $0.78M |
| Total Current Liabilities | $10.50M | $6.92M | $7.55M | $4.61M | $1.65M |
| Long-Term Debt | $0.00M | $19.34M | $30.93M | $24.90M | $4.99M |
| Total Liabilities | $35.02M | $50.82M | $38.49M | $29.51M | $6.64M |
| Stockholders Equity | |||||
| Retained Earnings | ($229.36M) | ($219.68M) | ($219.25M) | ($203.20M) | ($179.49M) |
| Total Stockholders Equity | $35.05M | ($5.87M) | ($11.62M) | ($2.57M) | $15.77M |
| Total Liab & Equity(computed) | $70.07M | $44.95M | $26.86M | $26.94M | $22.41M |
| Debt Summary | |||||
| Total Debt | $0.00M | $19.34M | $30.95M | $24.90M | $4.99M |
| Net Debt | ($36.72M) | ($7.29M) | $17.68M | $1.13M | ($16.11M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Fennec Pharmaceuticals Inc. data
About Fennec Pharmaceuticals Inc. (FRX.TO) Balance Sheet
Fennec Pharmaceuticals Inc. (FRX.TO) balance sheet shows total assets of $0.07B with cash of $0.04B. Total liabilities are $0.04B, total debt $0.00B, and stockholders equity $0.04B.
Frequently asked questions
FRX.TO · 4 questionsFennec Pharmaceuticals Inc. has total debt of $0.00B with net debt of ($0.04B).
FRX.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10